All ProductsDisplaying Products Alphabetically by Name (T)
Cat. No. | Product Name / Activity |
---|---|
2373 | T 0901317 |
Potent liver X receptor (LXR) agonist; also CAR inverse agonist | |
7690 | T 112 |
Estrogen-related receptor γ agonist; promotes maturation of hiPSC-derived cardiomyocytes | |
6106 | T 3364366 |
Potent and reversible fatty acid desaturase 1 inhibitor; orally bioavailable | |
7317 | T 5224 |
Selective inhibitor of c-Fos/activator protein (AP)-1 | |
2301 | T 0070907 |
Highly potent and selective covalent PPARγ antagonist | |
4723 | T2AA |
PCNA inhibitor | |
6666 | T3 |
Thyroid hormone; also promotes differentiation of oligodendroglial precursor cells | |
7570 | T3 CLK |
Potent and selective pan-CLK inhibitor; also inhibits DYRK1A/B | |
TB6666-RMU | T3 |
T3 synthesized to Ancillary Material Grade | |
7054 | T4 |
Modulator of alternative polyadenylation; inhibits rod photoreceptor gene expression via Nr2e3 | |
3599 | TAK 165 |
Potent and selective ErbB2 inhibitor | |
5209 | TAK 21d |
Potent FAAH inhibitor | |
6587 | TAK 242 |
TLR4 signaling inhibitor | |
6777 | TAK 375 |
Very high affinity and selective melatonin receptor agonist | |
4254 | TAK 715 |
Potent p38 MAPK inhibitor; anti-inflammatory | |
4340 | TAK 779 |
Potent and selective CCR5 and CCR2 chemokine receptor antagonist | |
5403 | TAK 960 hydrochloride |
Potent and selective PLK1 inhibitor | |
7665 | 5-TAMRA NHS |
Fluorescent amine-reactive dye for labeling proteins, peptides and oligonucleotides, FRET acceptor for FAM | |
5523 | TAPI 0 |
ADAM-17 (TACE) and MMP inhibitor | |
6162 | TAPI 1 |
ADAM-17 (TACE) and MMP inhibitor | |
6013 | TAPI 2 |
ADAM-17 (TACE) and MMP inhibitor | |
6498 | TASP 0277308 |
Potent and selective S1P1 receptor antagonist; inhibits angiogenesis | |
5729 | TASP 0390325 |
Potent and selective V1B receptor antagonist; orally bioavailable | |
5362 | TASP 0433864 |
Selective positive allosteric modulator of mGlu2 receptors | |
6227 | TAT-Gap19 |
Cx43 hemichannel blocker | |
7402 | TAT-Gap19(I130A) |
Control peptide for TAT-Gap19 | |
7832 | TAT-PDHPS1 |
YAP inhibitor | |
7962 | TAT-SAMβA Peptide |
Selective antagonist of Mfn1-βIIPKC association | |
2905 | TB 21007 |
α5-selective GABAA inverse agonist | |
2275 | TBB |
Selective cell-permeable CK2 inhibitor | |
2825 | TBCA |
Selective CK2 inhibitor | |
7660 | TBI |
Fluorogenic ligand for Broccoli RNA aptamer | |
7788 | TBIA |
Bivalent SHAPE cross-linking reagent | |
7259 | TBK1 PROTAC® 3i |
Potent TANK-binding kinase 1 (TBK1) PROTAC® | |
7260 | TBK1 control PROTAC® 4 |
Negative control for TBK1 PROTAC® 3i (Cat. No. 7259) | |
1223 | DL-TBOA |
Selective non-transportable inhibitor of EAATs | |
7862 | TBTA |
Click chemistry auxiliary reagent; stabilizing ligand for copper-catalyzed azide-alkyne cycloaddition reaction | |
4300 | TC 14012 |
CXCR4 antagonist; ACKR3 (CXCR7) agonist | |
2737 | TC 2559 difumarate |
Selective α4β2 nAChR partial agonist | |
5412 | TC AQP1 1 |
Aquaporin 1 (AQP1) channel blocker | |
4825 | TC ASK 10 |
Potent and selective ASK1 inhibitor; orally bioavailable | |
6125 | TC JL 37 |
Potent TYK2 inhibitor | |
4708 | TC LPA5 4 |
LPA5 receptor antagonist | |
5087 | TC NTR1 17 |
Selective NTS1 partial agonist | |
4625 | TC OT 39 |
Potent non-peptide oxytocin receptor partial agonist; also V1a receptor antagonist | |
6884 | TC SL C5 |
Metastasis-associated lung adenocarcinoma transcript 1 (Malat1) RNA inhibitor | |
4066 | TC-A 2317 hydrochloride |
Potent, selective Aurora kinase A inhibitor | |
4301 | TC-DAPK 6 |
Potent and selective inhibitor of DAPK1 | |
5089 | TC-E 5002 |
Selective KDM2/7 inhibitor | |
4355 | TC-F 2 |
Potent, reversible and selective FAAH inhibitor | |
4624 | TC-FPR 43 |
Potent FPR2 agonist | |
4879 | TC-G 1001 |
GPR35 agonist; more potent than zaprinast (Cat. No. 0947) | |
4407 | TC-G 1004 |
Potent and selective A2A antagonist | |
5129 | TC-G 1005 |
Potent and selective GPBA receptor (TGR5) agonist | |
5355 | TC-G 1008 |
Potent and selective GPR39 agonist | |
4353 | TC-G 24 |
Potent and selective GSK-3β inhibitor | |
4527 | TC-I 15 |
Potent α2β1 inhibitor; displays antithrombotic activity in vivo | |
4632 | TC-I 2000 |
TRPM8 blocker | |
5410 | TC-I 2014 |
Potent TRPM8 antagonist | |
4365 | TC-MCH 7c |
Selective melanin-concentrating hormone receptor 1 (MCH1R) antagonist | |
4435 | TC-N 1752 |
NaV channel blocker | |
4961 | TC-S 7001 |
Potent and highly selective ROCK inhibitor; orally active | |
3567 | TC-S 7003 |
Potent Lck inhibitor | |
5088 | TC-S 7004 |
Potent and selective DYRK1A/B inhibitor | |
4459 | TC-S 7005 |
Potent and selective PLK2 inhibitor | |
5240 | TC-S 7006 |
Potent and selective Tpl2 (Cot; MAP3K8) inhibitor | |
5243 | TC-S 7009 |
High affinity and selective HIF-2α inhibitor | |
2592 | TCB-2 |
High affinity and potent 5-HT2A agonist | |
7489 | TCH-165 |
Enhancer of 20S proteasome assembly and 20S-mediated protein degradation | |
4154 | TCN 201 |
GluN1/GluN2A-selective NMDA antagonist | |
3818 | TCS 1102 |
Potent, dual orexin receptor antagonist | |
3869 | TCS 2002 |
Potent GSK-3β inhibitor | |
4221 | TCS 21311 |
Potent JAK3 inhibitor. Also inhibits GSK-3β and PKC | |
3900 | TCS 2314 |
α4β1 (VLA-4) antagonist | |
4069 | TCS 2510 |
Selective EP4 agonist | |
2591 | TCS 359 |
Potent FLT3 inhibitor | |
4465 | TCS ERK 11e |
Potent and selective ERK2 inhibitor | |
2827 | TCS JNK 5a |
Selective inhibitor of JNK2 and JNK3 | |
3222 | TCS JNK 6o |
Selective JNK inhibitor | |
TB3222-RMU | TCS JNK 6o |
TCS JNK 6o synthesized to Ancillary Material Grade | |
3371 | TCS OX2 29 |
Potent and selective OX2 antagonist | |
2979 | TCS PIM-1 1 |
Selective, ATP-competitive Pim-1 kinase inhibitor | |
8036 | TDI 11861 |
Soluble adenylyl cyclase inhibitor | |
6092 | TDZD 8 |
Selective non-ATP competitive inhibitor of GSK 3β | |
0645 | 2-TEDC |
5-, 12-, 15-Lipoxygenase inhibitor | |
7809 | TEPP 46 |
Potent and selective pyruvate kinase M2 (PKM2) allosteric activator | |
2532 | TFB-TBOA |
Potent and selective EAAT1 and EAAT2 blocker | |
5108 | TFC 007 |
Potent hematopoietic prostaglandin D synthase (H-PGDS) inhibitor | |
1464 | TFLLR-NH2 |
PAR1-activating peptide | |
3813 | TFM-4AS-1 |
Selective androgen receptor modulator (SARM) | |
7742 | TFRGAP-NH2 |
PAR3 peptide agonist | |
4336 | TG 003 |
Potent inhibitor of Clk-family kinases; also inhibits DYRK1A/B | |
5425 | TGN 020 |
Aquaporin 4 (AQP4) channel blocker | |
5832 | TGX 221 |
Potent and selective PI 3-kinase β inhibitor | |
7778 | TH 10785 |
OGG1 activator | |
7422 | TH 1760 |
Potent and selective NUDT15 hydrolase inhibitor | |
6534 | TH 5427 hydrochloride |
Potent NUDT5 inhibitor | |
6749 | TH 5487 |
Selective 8-oxoguanine DNA glycosylase 1 (OGG1) inhibitor | |
7719 | TH 9619 disodium salt |
MTHFD2 inhibitor | |
6532 | THAL SNS 032 |
Potent and selective Cdk9 Degrader (PROTAC®) | |
1990 | (R,R)-THC |
Potent subtype-selective ligand; ERα agonist/ERβ antagonist | |
6334 | THDOC |
Positive modulator of GABAA receptors; endogenous neurosteroid | |
0807 | THIP hydrochloride |
GABAA agonist | |
3032 | THIQ |
Potent and selective MC4 receptor agonist | |
7863 | THPTA |
Click chemistry auxiliary reagent; accelerating ligand for copper-catalyzed azide-alkyne cycloaddition reaction | |
6981 | TL 0259 |
Selective and highly potent Fgr and Lyn kinase inhibitor; orally bioavailable | |
6524 | TL 12-186 |
Multikinase Degrader (PROTAC®) | |
6746 | TL 13-110 |
Negative control for TL 13-112 (Cat. No. 6745) | |
6745 | TL 13-112 |
Selective ALK Degrader (PROTAC®) | |
6744 | TL 13-12 |
Selective ALK Degrader (PROTAC®) | |
6747 | TL 13-22 |
Negative control for TL 13-12 (Cat. No. 6744) | |
6525 | TL 13-27 |
Negative control for TL 12-186 (Cat. No. 6524) | |
5910 | TL4-12 |
Potent MAP4K2 (GCK) inhibitor | |
3051 | TLQP 21 |
VGF-derived peptide | |
7131 | TM 38837 |
Highly potent CB1 inverse agonist; peripherally restricted | |
5769 | TM 5275 sodium salt |
Plasminogen activator inhibitor-1 (PAI-1) inhibitor; orally bioavailable | |
6194 | TM 5441 |
Plasminogen activator inhibitor-1 (PAI-1) inhibitor | |
7917 | TM2 TEAD inhibitor |
Potent and reversible inhibitor of TEAD mediated Hippo/Yap signalling | |
5960 | TMI 1 |
Adam 17 (TACE) and MMP inhibitor; orally bioavailable | |
4253 | TMPyP4 tosylate |
Inhibitor of human telomerase | |
6802 | 6 TMR Tre |
Fluorescent trehalose; selectively labels mycobacterial cell envelope | |
3946 | TNP |
Inhibitor of IP6K; also inhibits IP3K | |
2464 | TNP-ATP triethylammonium salt |
Potent and selective P2X antagonist | |
4414 | TP 003 |
GABAA partial agonist; acts at benzodiazepine site | |
6008 | TP 064 |
Potent and selective PRMT 4 inhibitor | |
6670 | TP 238 |
CECR2 and BPTF/FALZ inhibitor | |
6000 | TP 472 |
Potent BRD9/7 inhibitor | |
5999 | TP 472N |
Negative control for TP 472 | |
7771 | TP-040 |
Potent and selective O-GlcNAcase (OGA) inhibitor | |
2559 | TPCA-1 |
Potent, selective inhibitor of IKKβ | |
4309 | TPEN |
Cell-permeable Zn2+ chelator; also inhibits RNA binding protein Lin28 | |
1040 | TPMPA |
Selective GABAA-ρ antagonist | |
5343 | TPPB |
High affinity PKC activator; also APP modulator | |
6908 | TR 14035 |
Potent integrin α4β7 and α4β1 (VLA-4) antagonist; orally bioavailable | |
8121 | TRAM 1 |
Chemical inducer of proximity for dTAG protein FKBPF36V and ecDHFR tags | |
2946 | TRAM 34 |
Potent and highly selective KCa3.1 (IK) channel blocker | |
3497 | TRAP-6 |
PAR1 peptide fragment (residues 42-47); acts as a PAR1 agonist | |
3163 | TRIS base |
Commonly used laboratory reagent; used to make TBS, TAE and TBE buffers | |
2906 | TRO 19622 |
Binds voltage-dependent anion channel (VDAC) | |
6875 | TRPC6-PAM-C20 |
Selective positive allosteric modulator (PAM) of TRPC6 | |
6831 | TRPV3 74a |
Selective TRPV3 antagonist; brain penetrant | |
7523 | TSA Vivid™ Fluorophore Kit 520 |
Signal amplification kit for use in ISH, ICC and IHC | |
7526 | TSA Vivid™ Fluorophore Kit 570 |
Signal amplification kit for use in ISH, ICC and IHC | |
7527 | TSA Vivid™ Fluorophore Kit 650 |
Signal amplification kit for use in ISH, ICC and IHC | |
0761 | TTNPB |
Retinoic acid analog; RAR agonist | |
4432 | TTP 22 |
High affinity, selective CK2 inhibitor | |
4601 | TUG 891 |
Potent and selective FFA4 (GPR120) agonist | |
7405 | TWS 119 |
Potent GSK3 inhibitor; induces neuronal and CD8(+) T cell differentiation | |
5328 | TY 52156 |
S1P3 receptor antagonist | |
2308 | Tabimorelin hemifumarate |
Potent, orally active ghrelin receptor agonist | |
6311 | Tadalafil |
Potent and highly selective PDE5 inhibitor; orally bioavailable | |
6430 | Takinib |
Potent and selective TAK1/MAP3K7 kinase inhibitor | |
3719 | Talabostat mesylate |
Potent DPP IV inhibitor; activates NLRP1b inflammasome | |
5032 | Talampanel |
Non-competitive non-NMDA iGluR antagonist | |
6342 | Tamoxifen |
Estrogen receptor partial agonist/antagonist | |
0999 | Tamoxifen citrate |
Estrogen receptor partial agonist/antagonist | |
3050 | Tamsulosin hydrochloride |
Selective α1A antagonist | |
2854 | Tandospirone hydrochloride |
Selective 5-HT1A partial agonist | |
6586 | Targapremir 210 |
Inhibits formation of miR-210 | |
5757 | Tariquidar dihydrochloride |
Potent P-glycoprotein (P-gp) inhibitor | |
7493 | Tasimelteon |
Selective dual melatonin receptor (MT1/MT2) agonist | |
7051 | Tasquinimod |
High affinity HDAC4 negative allosteric modulator; also binds S100A9; antiangiogenic | |
1097 | Taxol |
Promotes assembly and inhibits disassembly of microtubules | |
7315 | Taxol Janelia Fluor® 526 |
Green-fluorescent taxol derivative; binds microtubules. Used for: microtubules imaging. Application: confocal microscopy, super resolution microscopy. Suitable for live cell imaging | |
6267 | Taxol Janelia Fluor® 549 |
Yellow-fluorescent taxol derivative. Used for: microtubule staining. Application: flow cytometry, confocal microscopy, super resolution microscopy | |
6266 | Taxol Janelia Fluor® 646 |
Red-fluorescent taxol derivative. Used for: microtubule staining. Application: confocal microscopy, fluorescence microscopy; protocol available | |
8093 | Tazemetostat New |
Potent and selective EZH2 inhibitor | |
1122 | Telenzepine dihydrochloride |
Potent, selective M1 antagonist | |
2706 | Temozolomide |
DNA-methylating antitumor agent | |
3082 | Tempol |
Superoxide scavenger; antioxidant | |
5264 | Temsirolimus |
mTOR inhibitor; antitumor | |
2580 | Tenidap |
NSAID, cyclooxygenase (COX-1) inhibitor. Also opener of KIR2.3 | |
6975 | Teniposide |
DNA topoisomerase II inhibitor; viral transduction enhancer | |
3666 | Tenofovir |
Reverse transcriptase inhibitor | |
1506 | Terazosin hydrochloride |
α1 antagonist; PGK1 activator | |
6484 | Terbinafine hydrochloride |
Selective K2P9.1 (TASK-3) activator; also inhibits fungal squalene epoxidase | |
3948 | Terfenadine |
H1 antagonist. Also KV11.1 (hERG) and Kir6 (KATP) channel blocker | |
5069 | Teriflunomide |
Inhibitor of DHODH; active metabolite of Leflunomide | |
1316 | Tertiapin-Q |
Selective blocker of inward-rectifier K+ channels | |
3965 | Tesaglitazar |
PPARα/γ agonist | |
2175 | Tetrabenazine |
Potent inhibitor of vesicular monoamine transport | |
3068 | Tetraethylammonium chloride |
Non-selective K+ channel blocker | |
0312 | (RS)-(Tetrazol-5-yl)glycine |
Highly potent NMDA agonist | |
1078 | Tetrodotoxin |
Na+ channel blocker | |
1069 | Tetrodotoxin citrate |
Na+ channel blocker; citrate salt of tetrodotoxin (Cat. No. 1078) | |
0652 | Thalidomide |
Binds cereblon; also TNF-α synthesis inhibitor | |
7518 | Thalidomide 4'-ether-PEG1-azide |
Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
6686 | Thalidomide 4'-ether-PEG2-alkyne |
Cereblon ligand with PEG linker and terminal alkyne for onward chemistry | |
7519 | Thalidomide 4'-ether-PEG2-azide |
Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
6950 | Thalidomide 4'-ether-PEG3-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
7520 | Thalidomide 4'-ether-PEG3-azide |
Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
6951 | Thalidomide 4'-ether-PEG5-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
7329 | Thalidomide 4'-ether-alkylC2-acid |
Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
6850 | Thalidomide 4'-ether-alkylC2-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
7330 | Thalidomide 4'-ether-alkylC3-acid |
Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
7521 | Thalidomide 4'-ether-alkylC3-azide |
Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
7331 | Thalidomide 4'-ether-alkylC4-acid |
Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
6917 | Thalidomide 4'-ether-alkylC4-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
7332 | Thalidomide 4'-ether-alkylC5-acid |
Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
7522 | Thalidomide 4'-ether-alkylC5-azide |
Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
7333 | Thalidomide 4'-ether-alkylC6-acid |
Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
6627 | Thalidomide 4'-ether-alkylC6-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
7829 | Thalidomide 4'-ether-alkylC6-azide |
Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
7334 | Thalidomide 4'-ether-alkylC7-acid |
Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
7335 | Thalidomide 4'-ether-alkylC8-acid |
Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
7403 | Thalidomide 4'-ether-alkylC8-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
6966 | Thalidomide 4'-oxyacetamide-PEG1-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
6967 | Thalidomide 4'-oxyacetamide-PEG2-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
6467 | Thalidomide 4'-oxyacetamide-PEG3-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
6913 | Thalidomide 4'-oxyacetamide-alkylC1-PEG3-alkylC3-amine |
Cereblon ligand with alkyl-PEG-alkyl linker and terminal amine for onward chemistry | |
6949 | Thalidomide 4'-oxyacetamide-alkylC2-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
6300 | Thalidomide 4'-oxyacetamide-alkylC4-azide |
Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
6968 | Thalidomide 4'-oxyacetamide-alkylC6-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
6946 | Thalidomide 4'-oxyacetamide-alkylC8-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
7735 | Thalidomide 5'-amine-PEG1-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
7736 | Thalidomide 5'-amine-PEG2-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
7737 | Thalidomide 5'-amine-PEG3-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
7733 | Thalidomide 5'-amine-alkylC10-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
7988 | Thalidomide 5'-amine-alkylC6-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
7557 | Thalidomide 5'-amine-alkylC8-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
7456 | Thalidomide, 5'-fluoro |
Fluoro functionalized Thalidomide; cereblon ligand for PROTACs | |
6685 | Thalidomide, propargyl |
Alkyne-functionalized Thalidomide; 'click' cereblon ligand for PROTACs | |
6466 | Thalidomide-4-hydroxyacetate |
Carboxylic acid-functionalized Thalidomide; cereblon ligand for PROTACs | |
7288 | Thalidomide-Cyanine 5 |
High affinity cereblon fluorescent probe | |
1138 | Thapsigargin |
Potent inhibitor of SERCA ATPase | |
4390 | Thiamet G |
Potent O-GlcNAcase inhibitor | |
3845 | Thiazovivin |
ROCK inhibitor; improves the efficiency of fibroblast reprogramming and induction of iPSCs | |
3280 | 2-ThioUTP tetrasodium salt |
Potent and selective P2Y2 agonist | |
7122 | Thioflavin T |
Cell-permeable fluorescent amyloid stain. Used for: in vitro Aβ staining in brain tissues. | |
4061 | 6-Thioguanine |
Anticancer and immunosuppressive agent | |
0644 | Thioperamide |
H3 antagonist; also H4 inverse agonist | |
3070 | Thioridazine hydrochloride |
Dopamine receptor antagonist; antipsychotic | |
7005 | 4-Thiouridine |
Photoreactive uridine analog for RNA sequencing | |
1185 | Thrombin Receptor Agonist Peptide |
Causes platelet aggregation and secretion | |
4256 | Tiagabine hydrochloride |
Selective GAT-1 inhibitor; anticonvulsant | |
5579 | Tilfrinib |
Potent and selective breast tumor kinase (Brk) inhibitor | |
0826 | Tiotidine |
Potent and selective H2 antagonist | |
5902 | Tiotropium bromide |
Potent muscarinic receptor antagonist | |
5565 | Tiplaxtinin |
Plasminogen activator inhibitor-1 (PAI-1) inhibitor | |
7389 | Tissue Clearing Pro |
Tissue clearing reagent kit | |
7563 | Tissue Clearing Pro Reagent 1 |
Tissue clearing reagent | |
7390 | Tissue Clearing Pro-Organoid |
3D cell culture clearing reagent kit | |
3609 | Tizanidine hydrochloride |
α2 agonist | |
5390 | Tobramycin |
Aminoglycoside antibiotic | |
2540 | Tocrifluor T1117 |
Fluorescent cannabinoid ligand; fluorescent form of AM 251 (Cat. No. 1117) | |
7150 | Tocriscreen 2.0 Max |
Bioactive compound library for high-throughput screening, high-content screening, target validation and assay development; comprised of 1280 biologically active compounds (250 μL 10 mM DMSO solutions) | |
7152 | Tocriscreen 2.0 Micro |
Bioactive compound library for high-throughput screening, high-content screening, target validation and assay development; comprised of 1280 biologically active compounds (15 μL 10 mM DMSO solutions) | |
7151 | Tocriscreen 2.0 Mini |
Bioactive compound library for high-throughput screening, high-content screening, target validation and assay development; comprised of 1280 compounds (50 μL 10 mM DMSO solutions) | |
7350 | Tocriscreen Antiviral Library |
Antiviral compound library for high throughput screening, target validation, assay development and drug repurposing; contains 240 bioactive compounds (100 μL 10 mM DMSO solutions) | |
7578 | Tocriscreen Epigenetics 3.0 |
A library of 160 epigenetic compounds (100 μL, 10 mM DMSO solutions) for high throughput screening, high content screening, target validation and assay development | |
7200 | Tocriscreen FDA-Approved Drugs Library |
Drug repurposing library; a library of 190 compounds equivalent to active components of drug formulations approved by the FDA (100 μL 10 mM DMSO solutions) | |
8100 | Tocriscreen GPCR Compound Library |
A bioactive compound library of 240 GPCR compounds (100 μL 10 mM DMSO solutions) for high-throughput screening, high-content screening, target validation and assay development | |
7844 | Tocriscreen Kinase Inhibitor 3.0 |
A bioactive compound library of 210 kinase inhibitors (100 μL 10 mM DMSO solutions) for high-throughput screening, high-content screening, target validation and assay development | |
7340 | Tocriscreen Stem Cell Library |
A library of 120 stem cell compounds (100 μL 10 mM DMSO solutions) to explore stem cell reprogramming, differentiation, proliferation and signaling | |
6555 | TokeOni |
NIR-emission luciferin analog; ideal for deep tissue applications; orally bioavailable and brain penetrant | |
5864 | Tolcapone |
COMT inhibitor; also inhibits transthyretin aggregation | |
5181 | Tolvaptan |
Potent and selective vasopressin V2 receptor antagonist; renoprotective and orally active | |
2011 | Tomoxetine hydrochloride |
Potent and selective noradrenalin re-uptake inhibitor | |
3620 | Topiramate |
GluK1 antagonist; inhibits carbonic anhydrase (CA) II and IV; also positive allosteric modulator of GABAA receptors | |
4562 | Topotecan hydrochloride |
DNA topoisomerase I inhibitor; Camptothecin (Cat. No. 1100) analog | |
4247 | Torin 1 |
Potent and selective mTOR inhibitor | |
4248 | Torin 2 |
Potent and selective mTOR inhibitor | |
5270 | Toyocamycin |
Adenosine analog; antifungal antibiotic | |
1558 | Tracazolate hydrochloride |
Allosteric modulator of GABAA receptors | |
7709 | Trametinib |
Potent and selective MEK inhibitor; orally bioavailable | |
1098 | Tranilast |
Antiallergic; inhibits inflammatory mediator release from mast cells | |
3852 | Tranylcypromine hydrochloride |
Irreversible inhibitor of LSD1; also inhibits MAO | |
6336 | Trazodone hydrochloride |
5-HT2A and α1 adrenoceptor antagonist; also enhances neural differentiation; antidepressant and neuroprotectant | |
5349 | Treprostinil |
Potent prostacyclin (PGI2) analog | |
2337 | Trequinsin hydrochloride |
Highly potent PDE3 inhibitor | |
2472 | Triacsin C |
Inhibitor of acyl-CoA synthetase | |
1406 | Trichostatin A |
Potent histone deacetylase inhibitor | |
7814 | Tricyclic cytosine tC |
Fluorescent tricyclic cytosine analog for RNA imaging | |
3253 | Triptolide |
Inhibits RNAPII-mediated transcription; antitumor, anti-inflammatory and immunosuppressive | |
2191 | S-Trityl-L-cysteine |
Potent, selective inhibitor of mitotic kinesin Eg5 | |
7937 | Trofinetide |
IGF-1 synthetic analogue | |
3114 | Troglitazone |
Selective PPARγ agonist; antidiabetic agent | |
6002 | Trolox |
Antifade reagent; antioxidant vitamin E derivative; cell permeable and water soluble | |
2459 | Tropisetron hydrochloride |
Potent 5-HT3 antagonist; also α7 nAChR partial agonist | |
3863 | Trovafloxacin mesylate |
Antibiotic; inhibits bacterial DNA synthesis | |
3402 | Tubacin |
HDAC6 inhibitor; inhibits α-tubulin deacetylation | |
6270 | Tubastatin A hydrochloride |
Potent HDAC6 inhibitor | |
2820 | (+)-Tubocurarine chloride |
nAChR antagonist | |
7640 | Tucatinib |
Potent and selective ErbB2 inhibitor | |
3516 | Tunicamycin |
Antibiotic; GlcNAc phosphotransferase inhibitor |
Tocris Products by Catalog Number
0100020003000400050006000700080009001000110012001300140015001600170018001900200021002200230024002500260027002800290030003100320033003400350036003700380039004000410042004300440045004600470048004900500051005200530054005500560057005800590060006100620063006400650066006700680069007000710072007300740075007600770078007900800081008200830084008500860087008800